Drug Delivery

Long-acting injectables help with adherence, but what if an unfolding pill could provide an oral option?

Researchers develop a new platform to improve delivery of oligonucleotide therapies to muscle.

A new study reports targeted CRISPR delivery in retinal and neurological disease models – without viral vectors.

Proprietary nanovesicles technology has caught the eye of Eli Lilly. We find out why.

How next-generation drug delivery and advanced automation are set to transform pharma’s future.

Researchers demonstrate anticounterfeiting method that uses DNA oligos integrated into pharmaceutical products.

Regeneron’s Gary Herman discusses the future of genetic medicines and the role of new delivery systems.

Regular injections to the eye are a reality for many patients. We must come up with better solutions for retinal degenerative diseases.

Maintaining the stability of vaccines over time and during temperature excursions is a crucial aspect of production, transport, and delivery.

As 3D printing gains traction in the pharma industry, its potential to revolutionize solid oral dosage forms is becoming clearer.